Notes
hepatitis B surface antigen
Reference
Lee D, et al. Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea. Cost Effectiveness and Resource Allocation : 15 Feb 2018. Available from: URL: https://doi.org/10.1186/s12962-018-0088-9
Rights and permissions
About this article
Cite this article
Antiviral prophylaxis cost effective for perinatal hep B prevention. PharmacoEcon Outcomes News 797, 8 (2018). https://doi.org/10.1007/s40274-018-4717-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4717-5